Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
My experience has been mostly positive. As with any start-up, there have been challenges. However, I do what I can to contribute positively and try not to get caught up in negativity. I feel more opps for dvlpm't into other roles and education would help with retention & job satisfaction.
¿Qué es lo que más te gusta de tu equipo directivo?
Transparency & willingness to collaborate and help when needed.
Revisión
¿Qué es lo que te hace más feliz en el trabajo?
Making a difference in the life of a patient.
Revisión
¿Por qué te sientes menospreciado y que podría hacerte sentir mejor sobre tu compensación?
I was brought on board at less than my colleagues and have been in "making it up" mode ever since.
Revisión
¿Qué son algunas de las mejores cosas de tu equipo?
We are very supportive of each other and celebrate each other's successes. We also contribute to each other's success whenever possible.
Revisión
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
That we are a start-up and are faced with challenges that require attention to overcome. I feel like I am making a positive contribution to the current and future success of the organization.
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×